SMTL ID : 7woj.1

Crystal structure of HSA-Myr complex soaked with cisplatin for one week

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.89 Å

Oligo State

monomer

Ligands

9 x CPT: Cisplatin(Covalent)(Non-covalent)

CPT.1: 3 residues within 4Å: Chain A: Y.358, H.362, Y.365 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.358, A:Y.365 Metal complexes: A:H.362 CPT.2: 5 residues within 4Å: Chain A: F.252, D.332, F.333, M.353, E.357 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.332, A:E.357 CPT.3: 2 residues within 4Å: Chain A: M.572 Ligands: MYR.13 No protein-ligand interaction detected (PLIP) CPT.4: 2 residues within 4Å: Chain A: F.151, H.152 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.152 Metal complexes: A:H.152 CPT.5: 4 residues within 4Å: Chain A: K.460, H.464, K.468, Y.476 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.476 Metal complexes: A:H.464 CPT.6: 3 residues within 4Å: Chain A: R.138, R.169, H.170 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:H.170 CPT.7: 1 residues within 4Å: Chain A: H.271 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:H.271 CPT.8: 2 residues within 4Å: Chain A: M.322, R.361 No protein-ligand interaction detected (PLIP) CPT.9: 3 residues within 4Å: Chain A: E.110, Q.128, H.129 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.129 Metal complexes: A:H.129

6 x MYR: MYRISTIC ACID(Non-covalent)

MYR.10: 12 residues within 4Å: Chain A: R.141, M.147, F.158, L.159, Y.162, L.163, L.178, A.182, Y.185, F.189, L.206, R.210 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:R.141, A:F.158, A:L.159, A:Y.162, A:Y.162, A:L.163, A:L.178, A:A.182, A:Y.185, A:Y.185, A:F.189, A:L.206 Hydrogen bonds: A:Y.185 Salt bridges: A:R.141 MYR.11: 11 residues within 4Å: Chain A: L.38, F.43, V.47, Y.174, P.176, L.275, A.278, A.282, L.307, L.308, S.311 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.38, A:F.43, A:V.47, A:A.278, A:L.307, A:L.308 Hydrogen bonds: A:Y.174, A:S.311 MYR.12: 13 residues within 4Å: Chain A: L.411, N.415, Y.435, V.439, V.442, L.447, L.454, L.477, L.481, L.484, R.509, F.512, S.513 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:Y.435, A:Y.435, A:Y.435, A:Y.435, A:V.439, A:V.442, A:L.447, A:L.454, A:L.477, A:L.484, A:L.484, A:R.509, A:F.512, A:F.512 Hydrogen bonds: A:N.415, A:S.513 Salt bridges: A:R.434, A:K.438 MYR.13: 11 residues within 4Å: Chain A: Y.425, F.531, F.533, K.549, A.552, L.556, M.572, F.575, V.600, S.603 Ligands: CPT.3 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.531, A:F.533, A:K.549, A:A.552, A:L.556, A:M.572, A:F.575, A:F.575, A:F.575 Hydrogen bonds: A:Y.425, A:Y.425 Salt bridges: A:R.545, A:K.549 MYR.14: 16 residues within 4Å: Chain A: R.233, A.234, K.236, A.237, V.240, F.252, S.256, D.348, L.351, G.352, L.355, L.371, A.374, K.375, E.378, V.506 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:A.234, A:K.236, A:A.237, A:V.240, A:L.351, A:L.355, A:A.374, A:K.375, A:V.506 Hydrogen bonds: A:T.260 MYR.15: 12 residues within 4Å: Chain A: K.223, W.238, R.242, L.243, L.262, H.266, R.281, L.284, A.285, S.311, I.314, A.315 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:W.238, A:R.242, A:L.243, A:L.262, A:L.284, A:A.285, A:A.315 Salt bridges: A:K.223, A:H.266

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, S.L. et al., Crystallographic analysis of interaction between cisplatin and human serum albumin: Effect of fatty acid. Int.J.Biol.Macromol. (2022)

Release Date

2022-07-20

Peptides

Albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Albumin

Related Entries With Identical Sequence